MS drug holiday for Over-50s: safe or risky?
NCT ID NCT03653273
First seen Apr 15, 2026 · Last updated May 09, 2026 · Updated 3 times
Summary
This study looks at whether people over 50 with a stable, inactive form of secondary progressive multiple sclerosis can stop taking their disease-modifying therapy without worsening their disability. Researchers will follow 250 participants for two years to compare disability progression and quality of life between those who stop and those who continue medication. The goal is to reduce treatment burden and side effects while maintaining disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM
Marseille, France
-
AP-HP (La Pitié Salpêtrière)
Paris, France
-
CH Poissy
Poissy, France
-
CH Quimper
Quimper, France
-
CH de Chartres
Chartres, France
-
CH de Foch
Suresnes, France
-
CH de Libourne
Libourne, France
-
CHU Angers
Angers, France
-
CHU Brest
Brest, France
-
CHU Clermont-Ferrand
Clermont-Ferrand, France
-
CHU Dijon
Dijon, France
-
CHU Grenoble
Grenoble, France
-
CHU Lille
Lille, France
-
CHU Montpellier
Montpellier, France
-
CHU Nancy
Nancy, France
-
CHU Nantes
Nantes, France
-
CHU Nice
Nice, France
-
CHU Poitiers
Poitiers, France
-
CHU Rennes
Rennes, France
-
CHU Strasbourg
Strasbourg, France
-
CHU Tours
Tours, France
-
CHU de Bordeaux
Bordeaux, France
-
CHU de Nîmes
Nîmes, France
-
Fondation de Rothschild
Paris, France
-
Hospices Civils Lyon
Lyon, France
-
Hôpital Henri Mondor
Créteil, France
-
Hôpital Saint Vincent de Paul
Lille, France
Conditions
Explore the condition pages connected to this study.